Altomare, BS C, Kinzler, PhD ER, Buchhalter, PhD AR, Cone, PhD EJ, Costantino, PhD A. Laboratory-based testing to evaluate abuse-deterrent formulations and satisfy the Food and Drug Administration’s recommendation for Category 1 Testing. J of Opioid Management [Internet]. 2017 Dec. 7 [cited 2024 Nov. 24];13(6):441-8. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/769